Gabelli Funds LLC Paratek Pharmaceuticals, Inc. Transaction History

Gabelli Funds LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$1.52 - $2.8 $509,747 - $939,007	335,360 Added 972.06%	369,860 $817,000
Q1 2023 May 12, 2023	SELL	$1.37 - $2.54 $5,480 - $10,160	-4,000 Reduced 10.39%	34,500 $87,000
Q4 2022 Feb 13, 2023	SELL	$1.67 - $2.51 $15,030 - $22,589	-9,000 Reduced 18.95%	38,500 $71,000
Q2 2022 Aug 12, 2022	SELL	$1.73 - $3.09 $865 - $1,545	-500 Reduced 1.04%	47,500 $92,000
Q4 2021 Feb 11, 2022	BUY	$4.07 - $5.3 $20,350 - $26,500	5,000 Added 11.63%	48,000 $216,000
Q3 2021 Nov 12, 2021	BUY	$4.7 - $7.24 $155,100 - $238,920	33,000 Added 330.0%	43,000 $209,000
Q2 2021 Aug 13, 2021	SELL	$6.81 - $10.93 $31,326 - $50,278	-4,600 Reduced 31.51%	10,000 $68,000
Q1 2021 May 14, 2021	BUY	$6.14 - $8.31 $6,140 - $8,310	1,000 Added 7.35%	14,600 $103,000
Q4 2020 Feb 05, 2021	BUY	$4.58 - $7.14 $9,160 - $14,280	2,000 Added 17.24%	13,600 $85,000
Q2 2020 Aug 13, 2020	SELL	$2.97 - $5.22 $1,782 - $3,132	-600 Reduced 4.92%	11,600 $61,000
Q4 2019 Feb 14, 2020	SELL	$2.93 - $4.5 $91,709 - $140,850	-31,300 Reduced 71.95%	12,200 $49,000
Q3 2019 Nov 01, 2019	SELL	$3.08 - $5.76 $16,940 - $31,680	-5,500 Reduced 11.22%	43,500 $188,000
Q2 2019 Aug 02, 2019	SELL	$3.47 - $6.32 $17,350 - $31,600	-5,000 Reduced 9.26%	49,000 $196,000
Q4 2018 Jan 30, 2019	BUY	$4.8 - $11.6 $259,200 - $626,400	54,000 New	54,000 $277,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

Stay updated on Gabelli Funds LLC with notifications on news.